MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

13 Jul 2022 Evaluate
Glenmark Pharmaceuticals has informed that it enclosed a copy of press release regarding - Glenmark Pharmaceuticals and SaNOtize Announce Peer Reviewed Publication of Its Phase 3 Clinical Trials on SaNOtize''s Novel Nitric Oxide Nasal Spray for COVID-19 in Lancet Journal.

The above information is a part of company’s filings submitted to BSE.


Glenmark Pharma. Share Price

2517.40 61.40 (2.50%)
28-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1920.10
Dr. Reddys Labs. 1177.80
Cipla 1418.00
Lupin 2175.00
Zydus Lifesciences 1187.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: